| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAVENOUS | | 95 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | | 45 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, CHEWABLE / ORAL | 24.75 mg | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | EMULSION / TOPICAL | 0.2 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CAPSULE, EXTENDED RELEASE / ORAL | | 4 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUPPOSITORY / VAGINAL | NA | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / OPHTHALMIC | 0.01 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SYRUP / ORAL | 26.5 mg | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERINEURAL | | 80 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SUSPENSION / ENTERAL | | 2920 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | GEL / DENTAL | 0.4 %w/w | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / NASAL | 14 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | PASTE, DENTIFRICE / DENTAL | 0.05 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | GRANULE, FOR SUSPENSION / ORAL | 15.63 mg/5ml | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION, EXTENDED RELEASE / ORAL | | 4 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | FILM, SOLUBLE / BUCCAL | | 47 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / TOPICAL | | 24 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ELIXIR / ORAL | 800 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | | 351 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / ORAL | 1 mg/1ml | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | | 30 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | | 75 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RECTAL | 0.13 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | GRANULE / ORAL | NA | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET / ORAL | 1.8 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / OPHTHALMIC | 0.01 %w/w | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INFILTRATION | 0.35 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION / INTRA-ARTICULAR | | 25 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INFILTRATION | | 80 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RESPIRATORY (INHALATION) | 0.03 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | JELLY / TOPICAL | | 180 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAVENOUS | | 6 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SYSTEM / TOPICAL | | 1680 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | | 80 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | | 45 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SUSPENSION/ DROPS / ORAL | 12.85 mg/2.5ml | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RECTAL | 0.02 %w/v | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / TOPICAL | | 24 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | POWDER, FOR SOLUTION / ORAL | | 161 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRA-ARTICULAR | 0.24 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION, CONCENTRATE / ORAL | 1 mg/1ml | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SUSPENSION / ORAL | | 1080 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / TOPICAL | 0.2 %w/w | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERIDURAL | 1 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION / INTRAMUSCULAR | | 30 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO / TOPICAL | 0.15 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | OINTMENT / OPHTHALMIC | 0.05 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CAPSULE / ORAL | 160 mg | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER, FOR SOLUTION / ORAL | | 13 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / NASAL | 250 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CAPSULE, DELAYED RELEASE / ORAL | 4.2 mg | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SUSPENSION / INTRAMUSCULAR | 0.02 %w/v | | Exact identifier — unii candidate 68 equally ranked IID candidates |